“The 40-gene Expression Profile (40-GEP) Test Identifies Cutaneous Squamous Cell Carcinoma (cSCC) Patients at High Risk of Metastasis within Lower-Staged Tumors to Better Guide Treatment Decisions” (2024) SKIN The Journal of Cutaneous Medicine, 8(2), p. s385. doi:10.25251/skin.8.supp.385.